Your doctor's decision depends on your current dose, how long you have been on therapy, and why the gap happened
In the past year, there was news about the prevention of progression to diabetes with tirzepatide (Mounjaro/Zepbound, Eli Lilly), benefits of tirzepatide and semaglutide (Ozempic/Wegovy, Novo Nordisk) in other patient populations such as those with heart failure and chronic kidney disease, and mounting evidence for the triple-hormone agonist retatrutide (Eli Lilly)
The old-school rules of weight loss and health still apply Regular exercise, smart food choices and plenty of sleep - those basic, healthy lifestyle choices - are not only going to help you lose weight on a weight-loss drug but also help you keep it off, said Dafina Allen, an obesity medicine physician who runs a clinic in Saginaw, Michigan
The clinical side of the operation is genuinely strong: 91/100 in Safety & Legitimacy, 100/100 in both Patient Support and Medication Handling, and one of the most polished app experiences in the GLP-1 space
